KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Albemarle (ALB) EBT (2016 - 2025)

Albemarle (ALB) has disclosed EBT for 17 consecutive years, with -$600.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 74.88% year-over-year to -$600.3 million, compared with a TTM value of -$552.1 million through Dec 2025, up 68.7%, and an annual FY2025 reading of -$552.1 million, up 68.7% over the prior year.
  • EBT was -$600.3 million for Q4 2025 at Albemarle, down from $76.2 million in the prior quarter.
  • Across five years, EBT topped out at $1.3 billion in Q3 2024 and bottomed at -$2.4 billion in Q4 2024.
  • Average EBT over 5 years is -$30.3 million, with a median of -$8.5 million recorded in 2021.
  • The sharpest move saw EBT crashed 457.82% in 2021, then soared 860.41% in 2024.
  • Year by year, EBT stood at -$8.1 million in 2021, then surged by 10882.19% to $869.3 million in 2022, then crashed by 205.95% to -$921.0 million in 2023, then tumbled by 159.5% to -$2.4 billion in 2024, then skyrocketed by 74.88% to -$600.3 million in 2025.
  • Business Quant data shows EBT for ALB at -$600.3 million in Q4 2025, $76.2 million in Q3 2025, and -$9.0 million in Q2 2025.